Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell Carcinoma: a prospective evaluation

被引：0
|
作者：
M Staehler
N Haseke
A Roosen
T Stadler
M Bader
M Siebels
A Karl
CG Stief
机构：
[1] Klinikum Grosshadern,Department of Urology, University of Munich
来源：
European Journal of Medical Research | / 15卷
关键词：
renal cell carcinoma; sarcomatoid; chemotherapy; sorafenib; multi-kinase inhibitor; survival; angiogenesis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] SORAFENIB AFTER COMBINATION THERAPY WITH GEMCITABINE PLUS DOXORUBICINE IN PATIENTS WITH SARCOMATOID RENAL CELL CARCINOMA: A PROSPECTIVE EVALUATION
    Staehler, M.
    Haseke, N.
    Roosen, A.
    Stadler, T.
    Bader, M.
    Siebels, M.
    Karl, A.
    Stief, C. G.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (07) : 287 - 291
  • [2] A multicenter, prospective phase II trial of gemcitabine plus axitinib in patients with renal cell carcinoma with a predominant sarcomatoid component
    Inkeun Park
    Hyo Jin Lee
    Woo Kyoon Bae
    Shinkyo Yoon
    Jae Lyun Lee
    Investigational New Drugs, 2019, 37 : 1239 - 1246
  • [3] A multicenter, prospective phase II trial of gemcitabine plus axitinib in patients with renal cell carcinoma with a predominant sarcomatoid component
    Park, Inkeun
    Lee, Hyo Jin
    Bae, Woo Kyoon
    Yoon, Shinkyo
    Lee, Jae Lyun
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (06) : 1239 - 1246
  • [4] Combination of Gemcitabine and Doxorubicin in Rapidly Progressive Metastatic Renal Cell Carcinoma and/or Sarcomatoid Renal Cell Carcinoma
    Roubaud, G.
    Gross-Goupil, M.
    Wallerand, H.
    de Clermont, H.
    Dilhuydy, M. S.
    Ravaud, A.
    ONCOLOGY, 2011, 80 (3-4) : 214 - 218
  • [5] A prospective phase II trial of gemcitabine plus axitinib in patients with sarcomatoid type renal carcinoma.
    Park, Inkeun
    Lee, Hyo Jin
    Bae, Woo Kyun
    Yoon, Shinkyo
    Lee, Jae-Lyun
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [6] Sorafenib in Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation
    Lekili, Murat
    Muezzinoglu, Talha
    Nese, Nalan
    Temeltas, Gokhan
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2010, 73 (05) : 262 - 264
  • [7] Combination of gemcitabine and doxorubicin in sarcomatoid and/or rapidly progressive metastatic renal cell carcinoma (MRCC)
    Roubaud, G.
    Dilhuydy, M. S.
    Pasticier, G.
    de Clermont, H.
    Smith, D.
    Rayaud, A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 308 - 309
  • [8] Novel combination therapy with imiquimod and sorafenib for renal cell carcinoma
    Karashima, Takashi
    Komatsu, Toshihiro
    Niimura, Mayumi
    Kawada, Chiaki
    Kamada, Masayuki
    Inoue, Keiji
    Udaka, Keiko
    Kuroda, Naoto
    Shuin, Taro
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (07) : 702 - 706
  • [9] Combination of antiangiogenic therapy and cytotoxic chemotherapy for sarcomatoid renal cell carcinoma
    Michaelson, M. Dror
    McDermott, David F.
    Atkins, Michael B.
    Cho, Daniel C.
    Olivier, Kara M.
    Schwarzberg, Abraham B.
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Sorafenib (Nexavarl®) with metastasis sarcomatoid renal cell cancer after failure of a previous chemotherapy with Doxorubicin and Gemcitabine
    Staehler, M.
    Schoeppler, G.
    Haseke, N.
    Stadler, T.
    Karl, A.
    Stief, C. G.
    ONKOLOGIE, 2008, 31 : 191 - 191
12345